Cargando…

Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men

PURPOSE: To investigate the potential benefits of testosterone administration to elderly men (>65 years) with late-onset hypogonadism (LOH) in comparison with younger men and to assess the safety of testosterone administration to elderly men. MATERIALS AND METHODS: A total of 561 hypogonadal men...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saad, Farid, Yassin, Aksam, Haider, Ahmad, Doros, Gheorghe, Gooren, Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392031/ https://www.ncbi.nlm.nih.gov/pubmed/25874045 http://dx.doi.org/10.4111/kju.2015.56.4.310

Ejemplares similares

Effects of Long-Term Testosterone Therapy on Patients with “Diabesity”: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes
por: Haider, Ahmad, et al.
Publicado: (2014)

Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study
por: Haider, Ahmad, et al.
Publicado: (2016)

Testosterone replacement therapy improves the health-related quality of life of men diagnosed with late-onset hypogonadism
por: Almehmadi, Yousef, et al.
Publicado: (2016)

Lower urinary-tract symptoms and testosterone in elderly men
por: Yassin, Aksam A., et al.
Publicado: (2008)

Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms
por: Saad, Farid, et al.
Publicado: (2018)

Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years
por: Haider, Ahmad, et al.
Publicado: (2014)

SUN-083 Hypertension and Hemodynamic Parameters in Men with Hypogonadism Improve Under Long-Term Treatment with Testosterone Undecanoate Injections (TU) Compared to Untreated Hypogonadal Control Patients
por: Saad, Farid, et al.
Publicado: (2019)

SAT-533 Men with Hypogonadism and Osteoporosis Benefit from Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU) Regardless of Co-Medication with Bisphosphonates: 10-Year Data from a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

Is there a relationship between the severity of erectile dysfunction and the comorbidity profile in men with late onset hypogonadism?
por: Yassin, Aksam A., et al.
Publicado: (2015)

Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
por: Yassin, AA, et al.
Publicado: (2013)

MON-091 Profound and Sustained Weight Loss in Men With Hypogonadism and Obesity Receiving Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

SUN-226 Improvements In Quality Of Life In Men With Hypogonadism Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): Experience From 6,500 Patient-years Ina Registry Study Ina Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

Effects of testosterone on the lower urinary tract go beyond the prostate: New insights, new treatment options
por: Saad, Farid, et al.
Publicado: (2011)

SUN-055 Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism Treated with Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Saad, Farid, et al.
Publicado: (2019)

OR21-2 Lipid Profiles Improve in Men With Hypogonadism and Pre-existing Cardiovascular Disease Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): 10-year Data From a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies
por: Saad, F, et al.
Publicado: (2016)

Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups
por: Traish, Abdulmaged M., et al.
Publicado: (2017)

Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study
por: Traish, A M, et al.
Publicado: (2014)

Testosterone as Potential Effective Therapy in Treatment of Obesity in Men with Testosterone Deficiency: A Review
por: Saad, Farid, et al.
Publicado: (2012)

Testosterone depot injection in male hypogonadism: a critical appraisal
por: Yassin, Aksam A, et al.
Publicado: (2007)

Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases
por: Kalinchenko, Svetlana, et al.
Publicado: (2009)

Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size
por: Yassin, Aksam, et al.
Publicado: (2023)

The role of the urologist in the prevention and early detection of cardiovascular disease
por: Yassin, Aksam A., et al.
Publicado: (2011)

The impact of long-term Testosterone Therapy (TTh) in renal function (RF) among hypogonadal men: An observational cohort study
por: Alwani, Mustafa, et al.
Publicado: (2021)

Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for “late-onset” hypogonadism: A case report
por: Haider, Ahmad, et al.
Publicado: (2019)

Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study
por: Saad, F., et al.
Publicado: (2020)

Late-onset hypogonadism: beyond testosterone
por: Foresta, Carlo, et al.
Publicado: (2015)

Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study
por: Haider, Karim Sultan, et al.
Publicado: (2020)

Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data
por: Alwani, Mustafa, et al.
Publicado: (2021)

Predictive factors for efficacy of testosterone replacement therapy for late-onset hypogonadism in Japanese men: a preliminary report
por: Kondoh, Nobuyuki, et al.
Publicado: (2023)

Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
por: Kim, Se Hwa
Publicado: (2014)

Cognitive effects of testosterone and finasteride administration in older hypogonadal men
por: Borst, Stephen E, et al.
Publicado: (2014)

Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
por: Dadhich, Pranav, et al.
Publicado: (2017)

Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
por: Ide, Veerle, et al.
Publicado: (2020)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

Commentary on “Late-onset hypogonadism - beyond testosterone”
por: Hackett, Geoffrey
Publicado: (2015)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
por: Shankara Narayana, Nandini, et al.
Publicado: (2021)

Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism
por: de Almeida Ferreira, Maurício, et al.
Publicado: (2022)

SHBG and total testosterone levels in men with adult onset hypogonadism: what are we overlooking?
por: Winters, Stephen J.
Publicado: (2020)

Remission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy
por: Haider, Ahmad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hdcl4185ikpf7bubr0l9t578be